or
forgot password

    • cancer clinical trials in sioux city, IA

    • Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
    Siouxland Hematology-Oncology Associates, LLP

    Trial Locations
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Siouxland Regional Cancer Center
    Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features
    Lycopene in Treating Patients With Metastatic Prostate Cancer
    Siouxland Hematology-Oncology
    Sioux City, Iowa 51101-1733
    Prostate Cancer
    Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Lymphoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    St. Luke's Regional Medical Center
    Siouxland Regional Cancer Center
    Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center
    Pancreatic Cancer
    Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
    Siouxland Hematology-Oncology
    Sioux City, Iowa 51101-1733
    Cancer Survivor, Sexual Dysfunction, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    St. Luke's Regional Medical Center
    Siouxland Regional Cancer Center
    Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center
    Breast Cancer
    Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
    St. Luke's Regional Medical Center

    Trial Locations
    St. Luke's Regional Medical Center
    Siouxland Regional Cancer Center
    Breast Cancer
    Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
    St. Luke's Regional Medical Center

    Trial Locations
    St. Luke's Regional Medical Center
    Siouxland Hematology-Oncology Associates
    Siouxland Regional Cancer Center
    Breast Cancer, Hot Flashes
    Levocarnitine in Treating Fatigue in Cancer Patients
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Unspecified Adult Solid Tumor, Protocol Specific
    Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Breast Cancer
    Everolimus in Treating Patients With Stage IV Melanoma
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Siouxland Regional Cancer Center
    Melanoma (Skin)
    Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Esophageal Cancer
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Mesothelioma
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Lung Cancer
    Bortezomib With or Without Irinotecan in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Head and Neck Cancer
    ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
    Siouxland Hematology-Oncology Associates

    Trial Locations
    Siouxland Hematology-Oncology Associates
    Siouxland Regional Cancer Center
    Breast Cancer
    Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
    St. Luke's Regional Medical Center

    Trial Locations
    St. Luke's Regional Medical Center
    Siouxland Regional Cancer Center
    Pancreatic Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    St. Luke's Regional Medical Center

    Trial Locations
    St. Luke's Regional Medical Center
    Siouxland Regional Cancer Center
    Breast Cancer
    Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Lung Cancer
    A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma
    Siouxland Hematology-Oncology
    Sioux City, Iowa 51101-1733
    Lymphoma, B-Cell